Medicine and Dentistry
Oxygen Therapy
100%
Staphylococcus aureus
100%
Endocarditis
100%
Tobramycin
100%
Hyperbaric Medicine
100%
Infective Endocarditis
36%
Immune Response
9%
Adjuvant Therapy
9%
Inflammatory Cytokine
9%
Interleukin-1
9%
Keratinocyte Derived Chemokine
9%
Diseases
9%
Cytokine
9%
Interleukin 6
9%
Infection
9%
Hospital Mortality
9%
Breathing
9%
Antibiotics
9%
Aortic Valve
9%
Myocardium
9%
Vasculotropin
9%
Keyphrases
Tobramycin
100%
Hyperbaric Oxygen Therapy
100%
Infective Endocarditis
36%
Staphylococcus Aureus
36%
Therapy Groups
36%
Bacterial Load
18%
Therapeutic Potential
9%
Clinical Score
9%
Host Response
9%
Myocardium
9%
Adjunctive Therapy
9%
Serious Disease
9%
Normobaric
9%
Interleukin-6
9%
Rat Model
9%
Keratinocyte-derived Chemokine
9%
Spleen
9%
Aortic Valve
9%
Cytokine Expression
9%
Quantitative Bacteriology
9%
Post-infection
9%
Twice Daily
9%
Inflammatory Cytokines
9%
Interleukin-1β
9%
Vascular Endothelial Growth Factor
9%
Antibiotic Response
9%
Clinical Status
9%
Air-breathing
9%
In-hospital Mortality
9%
Immunology and Microbiology
Staphylococcus aureus
100%
Endocarditis
100%
Bacterial Load
40%
Vasculotropin
20%
Bacteriology
20%
Hospital Mortality
20%
Keratinocyte Derived Chemokine
20%
Interleukin-1
20%
Interleukin 6
20%
Immune Response
20%
Rat Model
20%
Cytokine
20%
Proinflammatory Cytokine
20%
Breathing
20%
Aortic Valve
20%
Pharmacology, Toxicology and Pharmaceutical Science
Keratinocyte Derived Chemokine
20%